Shenzhen Laibao Hi-Tech Co., Ltd. (002106.SZ) Bundle
Curious who's buying into Shenzhen Laibao Hi‑Tech Co., Ltd. (002106.SZ) and why investors are buzzing? Peek behind the curtain at a company that reported a net income of 374.44 million yuan in 2024 (a 0.43% YoY rise), sits debt‑free, and trades at a compelling P/E of 20.9x versus the broader Chinese market's 36.1x; add plans for a $21 million overseas push into Singapore and Thailand, a government‑backed Microcavity Electrophoretic Display (MED) project, an announced cash dividend of 1.00 yuan per 10 shares, and an ownership structure led by founder and CEO Shaozong Li-factors that explain why individuals and institutions (holding about 9.06% as of October 22, 2025) are weighing in on its future-read on to see which investors are putting money behind these signals and what it means for market sentiment.
Shenzhen Laibao Hi-Tech Co., Ltd. (002106.SZ) - Who Invests in Shenzhen Laibao Hi-Tech Co., Ltd. and Why?
- Individual investors
Retail investors are drawn to Shenzhen Laibao Hi-Tech for its core position in electronic components (upstream materials and touch devices for flat panel displays) which tie directly to consumer electronics demand, perceived growth potential in display technologies, and visible corporate actions such as dividends and international expansion.
- Institutional investors
Funds, asset managers and strategic investors favor the company for its steady profitability, conservative balance sheet and targeted R&D initiatives that point to scalable future revenues.
| Investor Type | Primary Motivations | Key Data Points |
|---|---|---|
| Individual (Retail) | Industry exposure, dividend income, growth story | Dividend: 1.00 yuan per 10 shares; exposure to display supply chain |
| Institutional | Stable profitability, valuation and low leverage | Net income 2024: 374.44 million yuan (+0.43% YoY); PE: 20.9x; Debt: zero |
| Strategic / Corporate | Technology partnerships, supply-chain integration | MED project collaboration with local government; upstream materials expertise |
| Global expansion-focused investors | International growth and production footprint | $21 million planned investment in Singapore & Thailand facilities |
- Why investors buy - concise drivers
- Financial health: debt-free balance sheet provides downside protection and flexibility.
- Valuation: company PE of 20.9x versus broader Chinese market PE ~36.1x, offering relative value.
- Profitability: net income of 374.44 million yuan in 2024, up 0.43% YoY, signaling stable earnings.
- Shareholder returns: planned cash dividend of 1.00 yuan per 10 shares.
- Growth initiatives: MED (Microcavity Electrophoretic Display) project with local government support suggests technology-led expansion.
- Geographic expansion: $21M investment to establish overseas business institutions and production in Singapore and Thailand targets new markets and supply-chain diversification.
Key metrics snapshot:
| Metric | Value |
|---|---|
| Net income (2024) | 374.44 million yuan (+0.43% YoY) |
| PE ratio | 20.9x |
| Chinese market PE (comparison) | 36.1x |
| Debt | None (debt-free) |
| Dividend | 1.00 yuan per 10 shares (cash) |
| Planned overseas investment | $21 million (Singapore & Thailand) |
| Strategic project | Microcavity Electrophoretic Display (MED) - local government collaboration |
Further context on corporate direction and stated values: Mission Statement, Vision, & Core Values (2026) of Shenzhen Laibao Hi-Tech Co., Ltd.
Shenzhen Laibao Hi-Tech Co., Ltd. (002106.SZ) - Institutional Ownership and Major Shareholders of Shenzhen Laibao Hi-Tech Co., Ltd. (002106.SZ)
As of October 22, 2025, institutional investors hold approximately 9.06% of Shenzhen Laibao Hi-Tech's shares, reflecting a moderate level of institutional interest. The ownership structure is relatively concentrated, led by founder and CEO Shaozong Li, whose sizeable personal stake signals strong insider confidence while concentrating voting power.
- Institutional ownership (10/22/2025): 9.06%
- Largest individual shareholder: Shaozong Li (Founder & CEO) - holds a significant stake
- Ownership profile: concentrated among a few major shareholders
- Debt status: debt-free (no on-balance-sheet interest-bearing debt reported)
- Company engagement: active disclosure and targeted outreach to institutional investors
- Strategic expansion: plans to establish overseas business institutions and production facilities
| Metric | Value / Status | Implication |
|---|---|---|
| Institutional Ownership (10/22/2025) | 9.06% | Moderate institutional footprint - room for additional institutional accumulation |
| Largest Shareholder | Shaozong Li (Founder & CEO) - significant stake | Strong insider alignment; concentrated governance |
| Debt | Debt-free | Lower financial risk; attractive to conservative institutions |
| Investor Relations Activity | Regular filings and strategic disclosures | Improves transparency and institutional receptivity |
| Growth/Expansion Plans | Establish overseas business institutions & production facilities | Potential catalyst for institutional interest and diversification of revenue |
Why institutions are (or may become) buyers
- Low leverage profile: debt-free balance sheet supports capital preservation mandates.
- Insider-aligned management: founder/CEO ownership reduces agency risk for long-term investors.
- Transparency and engagement: active IR and detailed financial reporting lower due-diligence friction.
- Expansion optionality: overseas institutions and facilities create an identifiable growth narrative.
- Concentrated ownership: can enable decisive strategic moves, though it raises minority governance considerations.
Key considerations institutional investors weigh
- Scope for increasing institutional stake given current 9.06% ownership versus free-float liquidity.
- Impact of concentrated insider holdings on corporate governance and exit/liquidity pathways.
- Execution risk and capex requirements tied to overseas production and institutional expansion.
- Potential valuation premium for a debt-free, founder-led company with clear disclosure practices.
For the company's stated mission, strategic vision and core values (updated to 2026), see: Mission Statement, Vision, & Core Values (2026) of Shenzhen Laibao Hi-Tech Co., Ltd.
Shenzhen Laibao Hi-Tech Co., Ltd. (002106.SZ) Key Investors and Their Impact on Shenzhen Laibao Hi-Tech Co., Ltd. (002106.SZ)
Shenzhen Laibao Hi-Tech's investor base combines founder-led control, institutional holdings, strategic project partners, and retail shareholders-each shaping strategy, governance and market perception.
- Founder & CEO influence: Shaozong Li, as a major shareholder and CEO, anchors strategic direction and decision-making, providing continuity and confidence to markets and other investors.
- Institutional holders: Institutions own approximately 9.06% of shares, offering financial stability, potential governance oversight, and advocacy for shareholder value.
- Strategic/sovereign/private partners: Planned investments and local-government collaborations attract partner capital and policy support, improving execution risk profiles.
- Retail investors: Responsive to dividends, earnings momentum and growth narratives (e.g., international expansion and MED development), amplifying short-term liquidity and sentiment swings.
Key corporate actions and metrics that shape investor behavior:
- Overseas expansion: planned establishment of business institutions and production facilities in Singapore and Thailand with a combined investment of US$21 million-seen as a catalyst for revenue diversification and global market access.
- Innovation initiative: the Microcavity Electrophoretic Display (MED) project-developed in collaboration with local government-signals R&D commitment and potential for differentiated product lines.
- Capital return: proposed cash dividend of 1.00 yuan per 10 shares (equivalent to 0.10 yuan per share), reinforcing shareholder returns and confidence in cash generation.
- Balance-sheet strength: company reports a debt-free financial status, reducing default and refinancing risks.
- Valuation context: trailing P/E ~20.9x versus broader Chinese market ~36.1x, implying comparative valuation support for investors seeking lower relative multiples.
| Metric | Value / Note |
|---|---|
| Founder & CEO | Shaozong Li (major shareholder; leads strategy & operations) |
| Institutional ownership | ≈ 9.06% |
| Overseas investment plan | US$21,000,000 (Singapore & Thailand facilities) |
| Key R&D project | Microcavity Electrophoretic Display (MED) - local government collaboration |
| Dividend plan | 1.00 yuan per 10 shares (0.10 yuan/share) |
| Net debt | Debt-free |
| Price-to-Earnings (P/E) | 20.9x |
| Broader Chinese market P/E | 36.1x |
Investor expectations and likely impacts:
- Confidence: Founder stewardship plus cash returns and a debt-free balance sheet tend to attract long-term and value-oriented investors.
- Governance pressure: Institutional holders (~9.06%) can push for stronger disclosure, board accountability and performance targets.
- Growth orientation: US$21M regional investments and MED collaboration improve growth narrative, appealing to growth-focused and thematic investors (display tech, internationalization).
- Valuation arbitrage: Lower P/E versus market can draw investors seeking relatively cheaper exposure to Chinese tech-manufacturing names with solid balance sheets.
For contextual framing of corporate purpose and medium-term strategic priorities, see: Mission Statement, Vision, & Core Values (2026) of Shenzhen Laibao Hi-Tech Co., Ltd.
Shenzhen Laibao Hi-Tech Co., Ltd. (002106.SZ) - Market Impact and Investor Sentiment
Shenzhen Laibao Hi-Tech's 2024 performance-highlighted by a net income of 374.44 million yuan-has materially influenced market perception, underpinning stronger investor confidence in the company's earnings quality and operational stability. Key strategic initiatives, notably the Microcavity Electrophoretic Display (MED) project and explicit plans to establish overseas business institutions and production facilities, are driving investor expectations for higher long-term growth and international revenue diversification.- Profitability: Net income of 374.44 million yuan in 2024, with consistent revenue growth trends reported across recent fiscal years.
- Valuation edge: Trailing P/E of 20.9x versus the broader Chinese market P/E of 36.1x, presenting relative value for earnings-backed exposure.
- Balance sheet strength: Reported debt-free status, reducing leverage risk and increasing financial flexibility for capex and expansion.
- Shareholder returns: Proposed cash dividend of 1.00 yuan per 10 shares, signaling management confidence and supporting yield-oriented investors.
- Strategic growth: MED project and overseas facility plans anticipated to expand TAM (total addressable market) and support margin improvements over time.
- Ownership concentration: A small number of major shareholders hold substantial stakes-facilitating decisive governance but raising potential minority influence concerns.
| Metric | Value |
|---|---|
| Net income (2024) | 374.44 million yuan |
| Trailing P/E | 20.9x |
| China market trailing P/E | 36.1x |
| Debt | Nil / Debt-free |
| Proposed dividend | 1.00 yuan per 10 shares (0.10 yuan/share) |
| Major initiatives | Microcavity Electrophoretic Display (MED); overseas business & production expansion |
| Ownership concentration | High (few major shareholders with substantial stakes) |

Shenzhen Laibao Hi-Tech Co., Ltd. (002106.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.